Editorial: Post-Exposure Prophylactic Neutralizing Monoclonal Antibodies to SARS-CoV-2 for Individuals at High Risk for COVID-19

Related articles

01 Jul 2023 : Editorial

Editorial: Post-Acute Sequelae of SARS-CoV-2 Infection (PASC). Updated Terminology for the Long-Term Effects of COVID-19

Dinah V. Parums,

DOI: 10.12659/MSM.941595

01 Sep 2023 : Editorial

Editorial: A Rapid Global Increase in COVID-19 is Due to the Emergence of the EG.5 (Eris) Subvariant of Omicron SARS-CoV-2

Dinah V. Parums,

DOI: 10.12659/MSM.942244

01 Oct 2023 : Editorial

Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution

Dinah V. Parums,

DOI: 10.12659/MSM.942672

28 Oct 2023 : Review article

A Review Article on Exercise Intolerance in Long COVID: Unmasking the Causes and Optimizing Treatment Strategies

Veronika Koleničová, Martina Sebalo Vňuková, [...] Martin Anders, Marta Fišerová, Jiří Raboch, Radek Ptáček - Show fewer authors

DOI: 10.12659/MSM.941079

01 Nov 2023 : Editorial

Editorial: Factors Driving New Variants of SARS-CoV-2, Immune Escape, and Resistance to Antiviral Treatments as the End of the COVID-19 Pandemic is Declared

Dinah V. Parums,

DOI: 10.12659/MSM.942960

01 Dec 2023 : Editorial

Editorial: Outbreaks of Post-Pandemic Childhood Pneumonia and the Re-Emergence of Endemic Respiratory Infections

Dinah V. Parums,

DOI: 10.12659/MSM.943312

03 Oct 2022 : Clinical Research

Effect of Vitamin D Concentration on Course of COVID-19

Magdalena Dominika Szerszeń, Aleksandra Kucharczyk, [...] Katarzyna Bojarska-Senderowicz, Monika Pohorecka, Andrzej Śliwczyński, Janusz Engel, Tomasz Korcz, Dariusz Kosior, Irena Walecka, Wojciech Stefan Zgliczyński, Waldemar Wierzba, Adam Jerzy Sybilski - Show fewer authors

DOI: 10.12659/MSM.937741

12 Oct 2022 : Review article

Effects of Physiotherapy on Rehabilitation and Quality of Life in Patients Hospitalized for COVID-19: A Review of Findings from Key Studies Published 2020-2022

Samire Beqaj, Amra Mačak Hadžiomerović, [...] Arzija Pašalić, Amila Jaganjac - Show fewer authors

DOI: 10.12659/MSM.938141

01 Dec 2022 : Editorial

Editorial: The World Health Organization (WHO) Fungal Priority Pathogens List in Response to Emerging Fungal Pathogens During the COVID-19 Pandemic

Dinah V. Parums,

DOI: 10.12659/MSM.939088

04 Jun 2022 : Editorial

Editorial: Acute Hepatitis of Unknown Origin in Children. Is Autoimmunity at Play?

Nahum Mendez-Sanchez, Shreya C. Pal

DOI: 10.12659/MSM.937371

10 Dec 2022 : Clinical Research

Retrospective Study to Identify Risk Factors for Severe Disease and Mortality Using the Modified Early Warning Score in 5127 Patients with COVID-19 Admitted to an Emergency Department in Poland Between March 2020 and April 2021

Sławomir Butkiewicz, Artur Zaczyński, [...] Igor Pańkowski, Piotr Tomaka, Ewa Rzońca, Daniel Ślęzak , Marcin Podgórski, Robert Gałązkowski, Jarosław Hiczkiewicz , Patryk Rzońca - Show fewer authors

DOI: 10.12659/MSM.938647

01 Mar 2022 : Editorial

Editorial: First Approval of the Protein-Based Adjuvanted Nuvaxovid (NVX-CoV2373) Novavax Vaccine for SARS-CoV-2 Could Increase Vaccine Uptake and Provide Immune Protection from Viral Variants

Dinah V. Parums,

DOI: 10.12659/MSM.936523

21 Mar 2022 : Review article

A Review of Recent Studies on the Effects of SARS-CoV-2 Infection and SARS-CoV-2 Vaccines on Male Reproductive Health

Leila Adamyan, Vladimir Elagin, [...] Valeriy Vechorko, Assia Stepanian, Anton Dashko, Dmitriy Doroshenko, Yana Aznaurova, Maxim Sorokin, Andrew Garazha, Anton Buzdin - Show fewer authors

DOI: 10.12659/MSM.935879

01 May 2022 : Editorial

Editorial: Cardiovascular Complications at One Year After SARS-CoV-2 Infection are Independent of Underlying Cardiovascular Risk Factors or Severity of COVID-19

Dinah V. Parums,

DOI: 10.12659/MSM.937048

04 May 2022 : Clinical Research

Comparison of the Prevalence of Antibodies to SARS-CoV-2 in 9954 Recruits in the Korean Army Training Center with the General Korean Population of Equivalent Age Between September and November, 2020

Kwang Ho Mun, Haebong Jang, [...] Hwanyeong Jeong, Jangkyu Choi, June-Woo Lee, Ah-Ra Kim , Su Hwan Kim, Sung Soon Kim, Donghyok Kwon , Dohsik Minn, Qyuen Park - Show fewer authors

DOI: 10.12659/MSM.934926

04 Jun 2022 : Clinical Research

Screening for SARS-CoV-2 Infection in Students at the Medical University of Warsaw, Poland Between November 15 and December 10, 2021 Using a Single Lateral Flow Test, the Panbio™ COVID-19 Ag Rapid Test

Mariusz Gujski, Paulina Mularczyk-Tomczewska, [...] Filip Raciborski, Piotr Samel-Kowalik, Łukasz Samoliński , Dorota Olczak-Kowalczyk, Mateusz Jankowski  - Show fewer authors

DOI: 10.12659/MSM.936962

01 Jul 2022 : Editorial

Editorial: World Health Organization (WHO) Variants of Concern Lineages Under Monitoring (VOC-LUM) in Response to the Global Spread of Lineages and Sublineages of Omicron, or B.1.1.529, SARS-CoV-2

Dinah V. Parums,

DOI: 10.12659/MSM.937676

01 Aug 2022 : Editorial

Editorial: Long-Term Effects of Symptomatic and Asymptomatic SARS-CoV-2 Infection in Children and the Changing Pathogenesis of Common Childhood Viruses Driven by the COVID-19 Pandemic

Dinah V. Parums,

DOI: 10.12659/MSM.937927

28 Feb 2022 : Clinical Research

Experience of the Polish Medical Air Rescue Service During the First Year of the COVID-19 Pandemic and Measures Taken to Protect Patients, Medical Staff, and Air Crew from SARS-CoV-2 Infection

Patryk Rzońca, Piotr Tomaka, [...] Ewa Rzońca , Robert Gałązkowski - Show fewer authors

DOI: 10.12659/MSM.935474

01 Oct 2022 : Editorial

Editorial: Rebound COVID-19 and Cessation of Antiviral Treatment for SARS-CoV-2 with Paxlovid and Molnupiravir

Dinah V. Parums,

DOI: 10.12659/MSM.938532

30 Aug 2021 : Editorial

Editorial: Reporting Clinical Trials with Important Modifications Due to Extenuating Circumstances, Including the COVID-19 Pandemic: CONSERVE 2021

Dinah V. Parums,

DOI: 10.12659/MSM.934514

04 Oct 2021 : Editorial

Editorial: A Decline in Influenza During the COVID-19 Pandemic and the Emergence of Potential Epidemic and Pandemic Influenza Viruses

Dinah V. Parums,

DOI: 10.12659/MSM.934949

06 Sep 2021 : Editorial

Editorial: First Full Regulatory Approval of a COVID-19 Vaccine, the BNT162b2 Pfizer-BioNTech Vaccine, and the Real-World Implications for Public Health Policy

Dinah V. Parums,

DOI: 10.12659/MSM.934625

20 Sep 2021 : Editorial

Editorial: Autoantibodies to Components of the Immune System, Including Type 1 Interferons, and the Risk of Severe COVID-19

Dinah V. Parums,

DOI: 10.12659/MSM.934766

11 Oct 2021 : Editorial

Editorial: Multisystem Inflammatory Syndrome in Adults (MIS-A) and the Spectrum of COVID-19

Dinah V. Parums,

DOI: 10.12659/MSM.935005

26 Apr 2021 : Editorial

Editorial: SARS-CoV-2 mRNA Vaccines and the Possible Mechanism of Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT)

Dinah V. Parums,

DOI: 10.12659/MSM.932899

10 May 2021 : Editorial

Editorial: The Pathogenesis of Long-Term Neuropsychiatric COVID-19 and the Role of Microglia, Mitochondria, and Persistent Neuroinflammation: A Hypothesis

George B. Stefano, Pascal Büttiker, [...] Simon Weissenberger, Anders Martin, Radek Ptacek, Richard M. Kream - Show fewer authors

DOI: 10.12659/MSM.933015

07 Jun 2021 : Editorial

Editorial: Long COVID, or Post-COVID Syndrome, and the Global Impact on Health Care

Dinah V. Parums,

DOI: 10.12659/MSM.933446

05 Jul 2021 : Editorial

Editorial: Maternal SARS-CoV-2 Infection and Pregnancy Outcomes from Current Global Study Data

Dinah V. Parums,

DOI: 10.12659/MSM.933831

19 Jul 2021 : Editorial

Editorial: Tocilizumab, a Humanized Therapeutic IL-6 Receptor (IL-6R) Monoclonal Antibody, and Future Combination Therapies for Severe COVID-19

Dinah V. Parums,

DOI: 10.12659/MSM.933973

02 Aug 2021 : Editorial

Editorial: The National COVID Cohort Collaborative Consortium Combines Population Data with Machine Learning to Evaluate and Predict Risk Factors for the Severity of COVID-19

Dinah V. Parums,

DOI: 10.12659/MSM.934171

09 Aug 2021 : Editorial

Editorial: Updates from the World Health Organization (WHO) on Global Treatment Recommendations for Drug-Susceptible and Multidrug-Resistant Tuberculosis

Dinah V. Parums,

DOI: 10.12659/MSM.934292